Ask AI
ProCE Banner Activity

Emerging CELMoD Strategies in DLBCL and FL: Interpreting the Data and Preparing for Practice

Slideset

Through this downloadable slideset, dive into the emerging role of CELMoDs in lymphoma with a focus on golcadomide in B-cell lymphomas, including diffuse large B-cell lymphoma and follicular lymphoma. Readers will explore the mechanism of action of CELMoDs, evolving clinical evidence across frontline and relapsed/refractory settings, combination strategies with chemoimmunotherapy and immune-directed therapies, and practical considerations for patient selection, treatment sequencing, and management of treatment-related adverse events.

Released: September 21, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Bristol Myers Squibb

Target Audience

This activity is intended for hematologists, oncologists, and other healthcare professionals involved in the diagnosis, treatment selection, longitudinal management, and supportive care of patients with B-cell lymphomas.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the biologic rationale and potential clinical relevance of CELMoD-based strategies in the treatment of patients with DLBCL/LBCL and FL

  • Interpret emerging efficacy and safety data for investigational CELMoD-based approaches and distinguish their potential role from current treatment options

  • Apply evidence-based principles to patient selection, toxicity monitoring and management, sequencing, and practice planning for the potential future integration of CELMoD-based strategies in B-cell lymphoma care

Additional Disclosures

Generative artificial intelligence (AI) tools were used for revising or refining educational content and generating transcript(s) from audio/video file. All AI-assisted content underwent human review, editing, and validation by qualified faculty and accredited education staff to ensure scientific accuracy, balance, and compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education.